utahmed8k20121210.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 7, 2012
Commission File No. 0-11178
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
|
UTAH
|
87-0342734
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
|
Registrant's telephone number:
|
(801) 566-1200
|
ITEM 1.01 Entry Into a Material Definitive Agreement
On December 7, 2012, Utah Medical Products, Inc. (UTMD) and JPMorgan Chase Bank, N.A. (Chase) modified the loan agreement they entered into on March 17, 2011 and subsequently amended on September 23, 2011. This second amendment reduces the monthly principal payment to $116,666.67 from $233,333.33. The 50% reduction is needed because UTMD has paid off $9.3 million of the $14.0 million initial loan amount in the first 20 months of the 5 year loan. A copy of the modification agreement is attached hereto as Exhibit 1.
ITEM 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
(d) Exhibits
|
Exhibit #
|
SEC
Reference #
|
Title of Document
|
|
111
|
|
|
| 1 |
10 |
Second Modification Agreement dated as of December 7, 2012 among Utah Medical Products, Inc., as Borrower, and JPMorgan Chase Bank, N.A., as Lender |
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
UTAH MEDICAL PRODUCTS, INC.
|
| |
REGISTRANT
|
|
Date: 12/10/2012
|
By: /s/ Kevin L. Cornwell
|
| |
Kevin L. Cornwell
|
| |
CEO
|